These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11383375)

  • 21. Should all patients with cardiovascular disease receive statin therapy?
    Vogel R; Schaefer E
    Am J Manag Care; 2001 May; 7(5 Suppl):S117-24. PubMed ID: 11383372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treating dyslipidemia with statins: the risk-benefit profile.
    Clark LT
    Am Heart J; 2003 Mar; 145(3):387-96. PubMed ID: 12660659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events.
    Ridker PM; Shih J; Cook TJ; Clearfield M; Downs JR; Pradhan AD; Weis SE; Gotto AM;
    Circulation; 2002 Apr; 105(15):1776-9. PubMed ID: 11956118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholesterol: precursor to many lipid disorders.
    Jones PH
    Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin therapy and stroke prevention: what was known, what is new and what is next?
    Mazighi M; Lavallée PC; Labreuche J; Amarenco P
    Curr Opin Lipidol; 2007 Dec; 18(6):622-5. PubMed ID: 17993806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statins and stroke prevention.
    Paciaroni M; Hennerici M; Agnelli G; Bogousslavsky J
    Cerebrovasc Dis; 2007; 24(2-3):170-82. PubMed ID: 17596685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new statin: a new standard.
    Olsson AG
    Am J Manag Care; 2001 May; 7(5 Suppl):S152-4. PubMed ID: 11383378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C; Olsson AG
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New results in the management of hypercholesterolemia].
    Sármán B
    Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Threshold level or not for low-density lipoprotein cholesterol.
    Barter PJ; Sacks FM
    Am J Manag Care; 2001 May; 7(5 Suppl):S125-31. PubMed ID: 11383373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statins and cerebrovascular disease: plaque attack to prevent brain attack.
    Mohler ER; Delanty N; Rader DJ; Raps EC
    Vasc Med; 1999; 4(4):269-72. PubMed ID: 10613632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Statin therapy of individuals with high risk for coronary disease].
    Holme I
    Tidsskr Nor Laegeforen; 1996 May; 116(12):1479-81. PubMed ID: 8650638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do statin drugs lower the risk of stroke?
    Sabharwal M; Por CP; Evans MF
    Can Fam Physician; 1998 May; 44():1003-4. PubMed ID: 9612584
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of therapeutic interchange from pravastatin to lovastatin in a Veterans Affairs Medical Center.
    Patel RJ; Gray DR; Pierce R; Jafari M
    Am J Manag Care; 1999 Apr; 5(4):465-74. PubMed ID: 10387386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "The lower the better" in hypercholesterolemia therapy: a reliable clinical guideline?
    Jacobson TA
    Ann Intern Med; 2000 Oct; 133(7):549-54. PubMed ID: 11015169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.